Assertio Holdings (ASRT) director exits as Zydus cash merger pays $23.50
Rhea-AI Filing Summary
Assertio Holdings, Inc. director Kirk Sigurd reported disposing of all remaining equity interests in connection with the company’s merger with Zydus. On June 16, 2026, 12,017 shares of common stock were cancelled and converted into the right to receive $23.50 per share in cash under a completed tender offer and merger.
The filing also shows the cancellation and disposition to the issuer of multiple stock option awards over 5,415 shares at $9.2565 per share, 5,415 shares at $15.1500 per share, and 7,913 shares at $17.1000 per share. According to the merger terms, in-the-money options were converted into cash based on the Offer Price, while options with exercise prices at or above $23.50 received no payment. Following these transactions, Sigurd reports zero shares and options remaining.
Positive
- None.
Negative
- None.
Insights
Director’s equity is cashed out as Assertio is taken private at $23.50.
This Form 4 reflects the mechanical cleanup of Kirk Sigurd’s equity as Assertio Holdings becomes a wholly owned subsidiary of Zydus. All common shares are cancelled for $23.50 per share in cash under the tender offer and subsequent merger.
Equity awards are treated according to standard merger terms. Restricted stock units become fully vested and convert into cash at the Offer Price. Stock options with exercise prices below $23.50 are cancelled and paid out based on the spread, while higher-strike options are simply cancelled with no payment.
For existing holders, this filing mainly confirms that Sigurd no longer has any economic exposure to Assertio’s equity after the June 16, 2026 effective time. It is an administrative step consistent with the already-agreed merger terms rather than a discretionary trading signal.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Disposition | Stock Option (Right to Buy) | 7,913 | $0.00 | -- |
| Disposition | Stock Option (Right to Buy) | 5,415 | $0.00 | -- |
| Disposition | Stock Option (Right to Buy) | 5,415 | $0.00 | -- |
| U | Common Stock | 12,017 | $0.00 | -- |
Footnotes (1)
- This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 13, 2026, by and among Assertio Holdings, Inc. (the "Issuer"), Zydus Worldwide DMCC ("Parent"), Zara Merger Sub Inc., a wholly owned subsidiary of Parent ("Purchaser") and Zydus Pharmaceuticals (USA) Inc., pursuant to which Purchaser completed a tender offer (the "Offer") for all outstanding shares of common stock of the Issuer ("Company Common Stock") at a price of $23.50 per share in cash, without interest (the "Offer Price"), and thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the "Merger"), effective as of June 16, 2026 (the "Effective Time"). At the Effective Time, each issued and outstanding share of Company Common Stock was cancelled and converted into the right [continues to Footnote 2] [continues from Footnote 1] to receive the Offer Price, less any applicable withholding taxes. Pursuant to the Merger Agreement, each restricted stock unit of the Issuer (each, a "Company RSU") that was outstanding but unvested immediately prior to the Effective Time became fully vested as of immediately prior to the Effective Time and, at the Effective Time, each outstanding Company RSU was cancelled and converted into the right to receive a cash payment, less any applicable withholding taxes, equal to the Offer Price. Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock (each, a "Company Stock Option") that was outstanding immediately prior to the Effective Time, whether vested or unvested, with an exercise price per share less than the Offer Price, was cancelled at the Effective Time and converted into the right to receive a cash payment, less any applicable withholding taxes, equal to the product of (A) the excess of the Offer Price over the exercise price payable per share of Company Common Stock under such Company Stock Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Stock Option. Each Company Stock Option with an exercise price per share equal to or greater than the Offer Price was cancelled at the Effective Time without any cash payment in respect thereof.